41 – 50 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
(
- Contribution to journal › Article
-
Mark
Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review
-
Mark
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
(
- Contribution to journal › Article